We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Meet Kevin Pricing Power ETF | AMEX:PP | AMEX | Exchange Traded Fund |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.5182 | 1.83% | 28.90 | 28.745 | 28.42 | 28.42 | 5,227 | 21:27:59 |
01-12584
(Commission
File Number)
|
13-3808303
(IRS
Employer Identification No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
(d)
|
Exhibits.
|
Exhibit 99.1 Press Release issued by Pipex Pharmaceuticals, Inc. dated August 14, 2008. |
Dated: August 14, 2008 | Pipex Pharmaceuticals, Inc. |
(Registrant) | |
By: /s/ Nicholas Stergis | |
Name: Nicholas Stergis | |
Title: Chief Executive Officer |
99.1
|
Press
Release issued by Pipex Pharmaceuticals, Inc. dated August 14,
2008
|
1 Year Meet Kevin Pricing Power... Chart |
1 Month Meet Kevin Pricing Power... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions